OMER
OMEROS CORP
Key Financials
Net Income
$-3350000
↑ 97.9%
Revenue
$73.8M
↑ 594.3%
Operating Income
$-122796000
↑ 27.5%
EPS (Diluted)
$-0.05
↑ 98.1%
Cash & Equivalents
$9.7M
↑ 184.1%
Total Assets
$325.6M
↑ 17.5%
Shareholders' Equity
$-121231000.00
↑ 33.6%
Long-term Debt
$87.9M
↓ 46.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/18/2026 | View on SEC |
| 3 | 8/18/2026 | View on SEC |
| 4 | 8/17/2026 | View on SEC |
| 144 | 8/13/2026 | View on SEC |
| S-8 | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
| 8-K | 8/12/2026 | View on SEC |
| SCHEDULE 13G/A | 7/29/2026 | View on SEC |
| 4 | 7/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OMER |
| Company Name | OMEROS CORP |
| CIK | 1285819 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | WA |
| Phone | 206-676-5000 |